Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...

Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on ...

The U.S. Senate has a plan to improve drug development for rare disease patients. The exit of controversial CBER chief Vinay Prasad will help clear the path.

It takes a long time, many different steps, and considerable cost, before a new drug can be approved for use as a medicine. One could be forgiven for thinking that, since billions of people across the ...

Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established ...

Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.

Agentic AI could reshape drug development. In this interview, Dr. Claudio D’Ambrosio discusses how agentic AI can identify novel drug compounds, improve trial design, and reduce operational ...

Kivo reports that the journey of prescription drugs involves extensive research, clinical trials, regulatory reviews, and ...

A surprising lab discovery reveals a light-powered way to tweak complex drugs faster, cleaner, and later in development.

Irish Pharmaceutical Healthcare Association president Shane Ryan is confident a new accord with Government can deliver for ...

Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...

Drug discovery is like molecular Tetris. Chemists snap atoms together, adjusting the pieces until everything fits, and ...